XANAX
XANAX
Approved
DIN Number
00548367
Drug Class
Human
Market Date
Dec 31, 1981
Company
HC
BGP Pharma ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00548367
AIG Number0115008002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA12 ALPRAZOLAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALPRAZOLAMActive
Strength: 0.5 MG
Monograph: ALPRAZOLAM